A new report from the National Academies of Sciences, Engineering, and Medicine (NASEM) provides a five-year strategic vision for the ...
Ridgeback Biotherapeutics LP, a closely held biotechnology company, and Drug Innovations at Emory (DRIVE), LLC, a not-for-profit biotechnology company wholly owned by Emory ...
Ridgeback Biotherapeutics and Drug Innovations at Emory (DRIVE) LLC, a not-for-profit biotechnology company wholly owned by Emory University, today announced ...
PharmaJet has announced that it received a $9.6 million dollar contract award from the Joint Science and Technology Office of ...
Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug ...
The Defense Threat Reduction Agency (DTRA) will convene the community of scientists, engineers, program managers and leaders in the defense ...
In a few short weeks, the Defense Threat Reduction Agency (DTRA) will host the 2019 Chemical and Biological Defense Science ...
The Federal Advisory Committee meeting of the Threat Reduction Advisory Committee (TRAC) will meet Monday, August 26 at the Pentagon ...
The Defense Threat Reduction Agency (DTRA) will host the 2019 Chemical and Biological Defense Science & Technology (CBD S&T) Conference ...
The Defense Threat Reduction Agency (DTRA), through its Biological Threat Reduction Program (BTRP) department, is seeking eligible performers to design ...
Spero Therapeutics, Inc. today announced that it was awarded funding of $15.7 million, with the potential for up to an additional $28.5 ...
The mission of the Cooperative Threat Reduction (CTR) program is to partner with willing countries to reduce threat from weapons ...
Overt symptoms of many diseases often do not manifest until days after a person's initial exposure to the causative pathogen, ...
No definitive diagnostic test exists for Burkholderia, a category B agent caused by Burkholderia pseudomallei bacterium, which poses a threat ...
A current Defense Threat Reduction Agency (DTRA) research effort, conducted by the U.S. Army Research Institute for Chemical Defense (USAMRICD), ...
Army Reserve Major Dana Perkins, PhD, an assistant professor in the Global Health Division of the Uniformed Services University of ...
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Virology Division, Pathogenesis and Immunology Branch has been tasked by ...
The Defense Threat Reduction Agency is seeking innovative technologies to accomplish automated text processing and visual analytics for biological materials ...
The Defense Threat Reduction Agency (DTRA) has announced intentions award a sole source contract to Technology Management Company (TMC) to ...
The Defense Threat Reduction Agency (DTRA) is seeking potential sources for chemical and biological counter-weapons of mass destruction (CWMD) laboratory ...
